IIT Kanpur and Apollo Hospitals join hands for research collaboration
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
Cipla and Ethris partner for the development of mRNA-based therapies
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation
Subscribe To Our Newsletter & Stay Updated